Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: November 2009
-
By Kevin E. Noonan — The highest form of tea leaf-reading is guessing how the Supreme Court will rule based on oral argument. Yet occasionally the Court's questioning suggests general trends and tendencies, and today's argument in Bilski v. Kappos may be one of those times. The claims at issue are directed to a…
-
By Christopher P. Singer — As reported a few weeks ago, the U.S. Patent and Trademark Office issued a pre-OG Notice regarding the way it will docket requests for continued examination (RCE) beginning on November 15, 2009. For any RCE that is filed on or after that date, the Office will place that RCE…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Novartis AG et al. v. Apotex Inc. et al.1:09-cv-06950; filed November 4, 2009 in the Northern District of Illinois • Plaintiffs: Novartis AG;…
-
November 9-10, 2009 – Patent Litigation 2009 (Practising Law Institute) – Atlanta, GA November 9-11, 2009 – Developing IP Strategies for Crystalline Forms*** (International Quality & Productivity Center) – London, England November 10, 2009 – The Patent Cooperation Treaty (PCT): Important Tool for Small and Medium-Sized Enterprises (SMEs) and Independent Inventors (World Intellectual Property Organization)…
-
On Monday, November 9, 2009, the Supreme Court will hear oral argument in In re Bilski, and two CLE providers plan to offer same day or next day coverage of the proceedings. Practising Law Institute (PLI) will be offering same day coverage on its Patent Practice Center blog. Gene Quinn, the editor of the Patent…
-
Managing IP and Lexis Nexis will be offering a free web seminar entitled: "Avoid Patent Unenforceability Claims Due to Inequitable Conduct" on November 12, 2009 from 12:00-1:30 PM (EST). J. Timothy Meigs of BD Technologies, Lawrence Sung of Dewey & LeBoeuf LLP, and Jeffrey Lindeman of Nixon Peabody LLP will provide tips for conducting the…
-
By Donald Zuhn — Patient Groups Back Senate and House Committee FOB Legislation In September, twenty-seven patients' groups sent a letter to Sen. Harry Reid (D-NV), Sen. Mitch McConnell (R-KY), Speaker of the House Nancy Pelosi (D-CA), and Rep. John Boehner (R-OH), expressing their "strong support for the inclusion of a regulatory pathway for…
-
By Suresh Pillai — Mayo Seeks Supreme Court Review in Prometheus Labs Case Following the U.S. Court of Appeals for the Federal Circuit's ruling that Prometheus Laboratories' method patents were valid under In re Bilski, the Mayo Clinic has petitioned the U.S. Supreme Court to review the ruling. The patents-in-suit, U.S. Patent Nos. 6,355,623…
-
By Donald Zuhn — Last Thursday, Rep. John Dingell (D-MI) introduced the Affordable Health Care for America Act (H.R. 3962) in the House of Representatives. The 1,990-page bill, which was co-sponsored by Rep. Robert Andrews (D-NJ), George Miller (D-CA), Frank Pallone, Jr. (D-NJ), Charles Rangel (D-NY), Pete Stark (D-CA), and Henry Waxman (D-CA), includes…
-
By Donald Zuhn — On October 23, twelve Senators sent a letter to Sen. Harry Reid (D-NV), asking the Senate majority leader to "support the establishment of a responsible pathway for the approval of follow-on biologic treatments, or 'biosimilars,' that ensures patient safety and includes 12 years of data exclusivity." The letter, which was…
Patent Docs 